Spirecut enters the scale-up phase
Spirecut, a Swiss medtech founded in 2020, develops ultrasound-guided, incision-free single-use Sono Instruments for percutaneous hand and foot procedures such as carpal tunnel release; the company received CE marking and FDA clearance in 2023, has treated over 5,000 patients across Europe, the US and Asia, and is scaling commercial infrastructure for office-based surgery while preparing a financing round to expand U.S. market penetration and clinical evidence.
Why it mattersAfter FDA clearance in 2023, Spirecut's scaling could shift part of 600,000 annual U.S.
Entities Mentioned
SpirecutFDA
People Mentioned
Damien VallélianWilliam SunLoïc VoillatFrédéric SchuindClémence HermannNihat Karaoglu